Why the study?
Can multimodality molecular imaging detect key cellular events in early aortic valve disease in vivo?
Can multimodality molecular imaging detect key cellular events in early aortic valve disease in vivo?
Answers are grounded in this paper and cite their sources.
Multimodality molecular imaging is capable of identifying early pathological cellular activities in aortic valve disease in vivo.
Molecular imaging can detect in vivo the key cellular events in early aortic valve disease, including endothelial cell and macrophage activation, proteolytic activity, and osteogenesis.
No takes yet. Share an insight, caveat, or question.
Aïkawa et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: